(Q38052176)

27 August 2017

Atopic dermatitis in children: management of pruritus (English)

1 reference

27 August 2017

1 reference

U Blume-Peytavi

1

1 reference

PubMed ID

23067431

27 August 2017

M Metz

series ordinal

2

1 reference

27 August 2017

1 November 2012

1 reference

Journal of the European Academy of Dermatology and Venereology

27 August 2017

1 reference

27 August 2017

26 Suppl 6

1 reference

27 August 2017

2-8

1 reference

Is eczema really on the increase worldwide?

27 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

The prevalence of childhood atopic eczema in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Psychiatric morbidity in dermatological outpatients: an issue to be recognized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Quality of life in infants with atopic dermatitis and healthy infants: a follow-up from birth to 24 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Addressing psychosocial aspects of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Effects of atopic dermatitis on young American children and their families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Nocturnal itch: why do we itch at night?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Sleep disturbances in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

A proposal: Atopic Dermatitis Organizer (ADO) guideline for children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

The impact of childhood atopic dermatitis on the patients' family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Integrating medical and psychological health care for children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Quality of life measures in Italian children with atopic dermatitis and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Association of stress with symptoms of atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: a nationwide, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Atopic dermatitis and attention-deficit/hyperactivity disorder: is there an association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Chronic pruritus--pathogenesis, clinical aspects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

The impact of pruritus on quality of life: the skin equivalent of pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Cowhage-induced itch as an experimental model for pruritus. A comparative study with histamine-induced itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

A role for polymodal C-fiber afferents in nonhistaminergic itch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Pruritus: an overview of current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Antihistamines in the treatment of dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Targeted treatment of pruritus: a look into the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Pediatric Atopic Dermatitis: A Review of the Medical Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

A pilot quality-of-life instrument for pruritus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Practice Gaps. Dermatologists should better integrate quality-of-life measures to inform and improve clinical decision making: comment on "The impact of pruritus on quality of life".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

European Guideline on Chronic Pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2012.04710.X

10.1111/J.1468-3083.2012.04710.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

23067431